3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Stomach Neoplasms
8
Carcinoma, Hepatocellular
8
Neoplasm Metastasis
7
Triple Negative Breast Neoplasms
6
Rectal Neoplasms
6
Nasopharyngeal Carcinoma
6
Melanoma
6
Lymphoma, Extranodal NK-T-Cell
6
Locally Advanced Rectal Cancer
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Nasopharyngeal Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Hemangiosarcoma
2
Gastrointestinal Stromal Tumors
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Interventions
spartalizumab
1
sintilimab
1
pyrotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Digestive System Tumor
×
spartalizumab
×
Clear all
NCT07053150
2025-07-08
CCGLC-018
Tongji Hospital
Phase 2
Not yet recruiting
80 enrolled